Research Article

Enhancement of Liver Targetability through Statistical Optimization and Surface Modification of Biodegradable Nanocapsules Loaded with Lamivudine

Table 2

Combinations of the formulation factors according to the selected factorial design and the observed results of characterization studies of LAM-ACNs.

Formulation codeFactor levelEEa (%)Particle size (nm)Zeta potential (mV)kc (h−1)
ABC

F1−1−1−121.59 ± 3.18305.2 ± 3.4−24.6 ± 1.50.243 ± 0.02
F2−10−132.14 ± 2.54289.3 ± 2.5−26.9 ± 1.70.224 ± 0.05
F3−1+1−128.42 ± 2.67274.3 ± 1.9−25.7 ± 0.90.206 ± 0.03
F4−1−1032.68 ± 3.22302.1 ± 5.2−26.3 ± 2.10.218 ± 0.03
F5−10048.29 ± 1.96286.5 ± 4.2−22.9 ± 2.30.186 ± 0.04
F6−1+1042.06 ± 4.06272.3 ± 2.6−25.3 ± 1.40.165 ± 0.02
F7−1−1+144.52 ± 3.28268.3 ± 2.1−24.3 ± 1.80.196 ± 0.06
F8−10+154.38 ± 4.25242.5 ± 3.2−24.9 ± 0.80.174 ± 0.03
F9−1+1+152.29 ± 2.98231.3 ± 1.8−26.2 ± 1.50.147 ± 0.04
F100−1−138.96 ± 2.17324.8 ± 2.7−25.6 ± 2.30.206 ± 0.03
F1100−143.58 ± 3.26318.2 ± 5.7−23.7 ± 1.70.197 ± 0.01
F120+1−142.19 ± 3.09304.3 ± 3.1−24.3 ± 1.10.165 ± 0.03
F130−1046.36 ± 4.21322.6 ± 3.6−22.9 ± 3.10.186 ± 0.02
F1400057.47 ± 3.84313.9 ± 2.3−24.1 ± 2.40.178 ± 0.06
F1400056.39 ± 2.61310.6 ± 1.4−25.3 ± 1.90.169 ± 0.04
F150+1052.62 ± 2.46299.6 ± 2.8−23.9 ± 1.80.154 ± 0.02
F160−1+159.72 ± 4.22315.9 ± 3.5−24.9 ± 2.10.143 ± 0.03
F1700+169.84 ± 1.96302.5 ± 2.2−25.4 ± 1.30.126 ± 0.05
F180+1+166.92 ± 2.05294.1 ± 4.7−23.7 ± 3.20.112 ± 0.02
F19+1−1−136.85 ± 2.31341.2 ± 4.3−28.1 ± 2.60.175 ± 0.04
F20+10−142.52 ± 1.87320.5 ± 3.9−27.3 ± 2.90.162 ± 0.03
F21+1+1−140.36 ± 3.04311.6 ± 1.5−25.2 ± 1.60.148 ± 0.04
F22+1−1052.39 ± 2.12336.1 ± 1.9−26.7 ± 1.20.159 ± 0.05
F23+10059.86 ± 3.28323.5 ± 2.4−24.6 ± 1.90.153 ± 0.02
F24+1+1053.58 ± 2.31308.1 ± 1.5−22.7 ± 0.70.138 ± 0.02
F25+1−1+163.93 ± 1.86322.5 ± 3.1−26.2 ± 2.20.121 ± 0.04
F26+10+173.41 ± 2.13302.4 ± 2.5−26.7 ± 2.10.108 ± 0.03
F27+1+1+169.35 ± 2.54286.9 ± 2.3−25.8 ± 2.70.094 ± 0.02

The results were expressed as average ± standard deviation for n = 3.